Yervoy® Postmarketing Surveillance for Patients in Japan With Unresectable, Malignant Melanoma

NCT02717364 · clinicaltrials.gov ↗
COMPLETED
Status
556
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Bristol-Myers Squibb

Collaborators